Palmetto GBA
Close Window [x]
  • Entire Site
  • J1 WPS Transition
  • J1 Part A
  • J1 Part B
  • LA & MS Part A EDI
  • NSC
  • Ohio Part B
  • Part A Intermediary
  • Railroad
  • RHHI
  • SC Part B
  • WV Part B
permaLink

Ohio Part B Carrier
New Waived Tests

MLN Matters® Number: MM6800
Related Change Request (CR) #: 6800
Related CR Release Date: February 5, 2010
Effective Date: April 1, 2010
Related CR Transmittal #: R1905CP
Implementation Date: April 5, 2010
 
Provider Types Affected
This article is for clinical laboratories and providers that submit claims to Medicare carriers or Medicare Administrative Contractors (MACs) for laboratory test services provided to Medicare beneficiaries.
 
Provider Action Needed
This article, based on Change Request (CR) 6800, alerts clinical laboratories and providers that the Centers for Medicare & Medicaid Services (CMS) has listed the latest tests approved by the Food and Drug Administration (FDA) as waived tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). The tests newly added to the waived tests are in the table in the Background section of this article. Be sure your billing staffs are aware of these changes.
 
Background
The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations require a laboratory facility to be appropriately certified for each test it performs. To ensure that Medicare & Medicaid only pay for laboratory tests categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver, laboratory claims are currently edited at the CLIA certificate level.
 
CMS identifies waived tests by providing an updated list of waived tests to Medicare contractors on a quarterly basis via a Recurring Update Notification. To be recognized as a waived test, some CLIA waived tests have unique Healthcare Common Procedure Coding System (HCPCS) procedure codes and some must have a QW modifier (CLIA Waived Test) included with the HCPCS code.
 
Listed in the table above are the latest tests approved by the FDA as waived tests under CLIA. The Current Procedural Terminology (CPT) codes for these new tests must have the QW HCPCS modifier to be recognized as a waived test.
 
However, please note that the codes for the tests mentioned on the first page of the attachment to CR 6800, at http://www.cms.hhs.gov/Transmittals/downloads/R1905CP.pdf do not require a QW HCPCS modifier to be recognized as a waived test (i.e., CPT codes: 81002, 81025, 82270, 82272, 82962, 83026, 84830, 85013, and 85651).  

CPT/HCPCS codes/HCPCS modifier
Effective Date
Description
80101QW,
G0430QW
July 1, 2009 for 80101QW,
 
January 1, 2010 for G0430QW
Inverness Medical Innovations Signify ER Drug Screen
82274QW,
G0328QW
September 9, 2009
Germaine Laboratories AimStep Immunological Fecal Occult Blood Test (iFOBT)
81003QW,
82044QW,
82570QW
September 14, 2009
Siemens Clinitek 50 Urine Chemistry Analyzer
87880QW
September 15, 2009
CLIA waived inc Rapid Strep A Test
82044QW
October 26, 2009
Genzyme Diagnostics OSOM ImmunoDip Urinary Albumin Test

Other Key Points of CR 6800
 
1. CR 6800 also announces that CMS was informed by Bayer Healthcare that the following tests are no longer manufactured or distributed; Hence, the following tests were removed from the attachment to CR 6800:
  • Bayer Mulitstick Pro 7G Reagent Strips;
  • Bayer Mulitstick Pro 10LS Reagent Strips;
  • Bayer Mulitstick Pro 11 Reagent Strips;
  • Bayer Clinitek 50 Urine Chemistry Analyzer,
  • Bayer Clinitek Status Urine Chemistry Analyzer;
  • Bayer Clinitek 50 Urine Chemistry Analyzer - for microalbumin, creatinine;
  • Bayer Diagnostics/ Microalbustix Reagent Strip; and
  • Bayer Clinitek 50 Urine Chemistry Analyzer - for HCG, urine.  
2. Based on a concern received from the laboratory industry on correct coding, the CPT code assigned to the following tests has been changed from CPT code 83518 HCPCS modifier QW to CPT code 82044 HCPCS modifier QW with an effective date of April 1, 2010:
  • Beckman Coulter ICON Microalb;
  • Boehringer Mannheim Chemstrip Micral;
  • Diagnostic Chemicals ImmunoDip™ Urinary Albumin Test;
  • Diagnostic Chemicals ImmunoDip™ Urinary Albumin Screen (Urine Dipstick); and
  • Roche Diagnostic Chemstrip Micral (urine dipstick).  
3. For 2010, the Healthcare Common Procedure Coding System (HCPCS) included the following new codes:
  • G0430 – Drug screen, qualitative; multiple drug classes other than chromatographic method, each procedure; and
  • G0431 – Drug screen, qualitative; single drug class method (e.g., immunoassay, enzyme assay), each drug class.  
Therefore, the HCPCS code/modiifer G0430QW was added to the following test systems since they are qualitative drug screening tests for multiple drug classes using a non-chromatographic method:
  • Abbott Diagnostics Signify ER Drug Screen Test;
  • Accu-Stat Drugs of Abuse Home Test for Marijuana (THC) and Cocaine (COC);
  • Accu-Stat Drugs of Abuse Home Test for Marijuana, Cocaine, Amphetamine, Methamphetamines, Opiates and Phencyclidine;
  • Accutest Multi-Drug, Multi-Line Screen Test Device;
  • Acon One Step Multi-Drug, Multi-Line Screen Test Device (Professional Use);
  • ADC CLIA Waived Marijuana (THC) and Cocaine Test;
  • ADC CLIA Waived Multiple Drug Test Card;
  • Advantage Diagnostics Advantage Marijuana (THC) and Cocaine Home Drug Test;
  • Advantage Diagnostics Corporation ADC Multiple Drug Test Card;
  • Alatex Scientific Peace of Mind Multiple Drugs of Abuse Test;
  • Alfa Scientific Designs, Inc. Instant View Multi-Drug of Abuse Urine Test;
  • Alfa Scientific Designs, Inc. Instant View Multi-Drug of Abuse Urine Cup Test;
  • Amedica Biotech Amedica Drug Screen Test Cup;
  • American Bio Medica Rapid TOX;
  • Aventir Biotech LLC Home Check Multiple Drug Test Cup;
  • Aventir Biotech LLC Home Check Multiple Drug Cup Test {Professional version};
  • Biotechnostix Rapid Response Multi-Drug, Multi-Line Screen Test Card with Integrated Cup;
  • Biotechnostix Rapid Response One Step Multi-Drug, Multi-Line Screen Test Device;
  • Branan Medical Corporation Fastect II Drug Screen Dipstick Test;
  • Branan Medical Corporation, FasTox Multiple Drug Dipcard;
  • Branan Medical Corporation, QuickTox Drug Screen Dipcard;
  • Branan Medical Corporation ToxCup Drug Screen Cup;
  • BTNX Inc. Know Multi-Drug One Step Screen Test Panel (Urine);
  • BTNX Inc. Rapid Response Multi-Drug One Step Screen Test Panel (Urine);
  • Drug Detection Devices Ltd. Multi-Drug Multi-Line Screeners Dip Drug Test With the Integrated Screeners AutoSplit KO Test Cup;
  • First Check Diagnostics First Check Multi Drug Cup;
  • First Check Diagnostics First Check 12 Drug Test;
  • Forefront Diagnostics Drugfree@Home THC/COC Test Kit;
  • iCassette Multi-Drug, Multi-Line Screen Test Device;
  • Innovacon Integrated E-Z Split Key Cup II {Professional Use};
  • Innovacon Multi-Clin Drug Screen Test Device;
  • Jant Pharmacal Accutest MultiDrug ER11 Drug Screen Test Device;
  • 1 Step Detect Associates DTX Drug Test Cup Integrated E-Z Split Key Cup II;
  • Phamatech At Home Drug Test (Model 9150T);
  • Quest Diagnostics Incorporated, Express Results Integrated Multi-Drug Screen Cup {professional use};
  • RediScreen Multi-Drug, Multi-Line Screen Test Device;
  • Redwood Toxicology Laboratory Reditest 6 Cassette substance abuse screening device {Professional Use};
  • Syntron Bioresearch Quikscreen Multiple Drug Cup Test {Professional version};
  • Twin Spirit, Inc. DrugSmart Cup;
  • Wolfe Drug Testing RealityCheck Integrated Specimen Cup;
  • Worldwide Medical Corporation, First Check® Home Drug Test (THC-COC); and
  • Worldwide Medical Corporation, First Check® Home Drug Test Panel 4 (THC-COC-OPI-MET). 
4. In addition, the HCPCS code G0431QW was added to the following test systems since they are qualitative drug screening tests using a single drug class method:
  • Accu-Stat Drugs of Abuse Home Test for Marijuana (THC);
  • ADC CLIA Waived Marijuana (THC) Test;
  • DyanGen NicCheck II Test Strips;
  • First Check Diagnostics LLC, First Check Home Drug Test Marijuana;
  • Mossman Associates, Inc. NicCheck I Test Strips;
  • Phamatech At Home Drug Test (Model 9068);
  • Phamatech At Home Drug Test (Model 9073);
  • Phamatech At Home Drug Test (Model 9073T);
  • Phamatech At Home Drug Test (Model 9078);
  • Phamatech At Home Drug Test (Model 9078T);
  • Phamatech At Home Drug Test (Model 9083);
  • Phamatech At Home Drug Test (Model 9133);
  • Phamatech QuickScreen One Step Cocaine Screening Test;
  • Phamatech QuickScreen One Step Methamphetamine Test;
  • Phamatech QuickScreen One Step Opiate Screening Test;
  • Phamatech QuickScreen One Step PCP Screening Test; and
  • Worldwide Medical Corporation, First Check® Home Drug Test (THC).  
You should be aware that your carrier or MAC will not search their files to either retract payment or retroactively pay claims processed prior to implementation of CR 6800. However, they should adjust claims that you bring to their attention.
 
Additional Information
You can find the official instruction, CR 6800, issued to your carrier or MAC by visiting http://www.cms.hhs.gov/Transmittals/downloads/R1905CP.pdf on the CMS website. You will find a table containing the tests granted waived status under CLIA as an attachment to that CR.
 
If you have questions, please contact the Palmetto GBA Provider Contact Center at their toll-free number (866) 332-7025 (Ohio and West Virginia) or (888) 828-2092 (South Carolina Part B).
 
Disclaimer
This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents. CPT only copyright 2009 American Medical Association.

 

last updated on 02/16/2010